The use of psychoactive drugs and driving – a return to rationality

The relationship between psychoactive drugs and the right to drive is complex and requires a nuanced assessment. Sim­plis­tic criminalization, influenced by political narratives and social stigma, ignores the legitimate medical context. Although these drugs can affect cognitive and motor func­tions, their impact varies depending on dosage, tolerance and use (therapeutic, recreational or abusive). Strict re­gu­la­tions can discourage appropriate treatment and amplify so­cial inequities. Objective assessments of driving ability are recommended, instead of decisions based solely on the pre­sence of the substance in the body. Policies should be based on scientific evidence, balancing road safety with ac­cess to essential treatments, through education and coun­seling. The overall objective was to outline a rational pic­ture of the link between psychoactive medication and the right to drive; in this regard, we conducted a narrative re­view that included 83 articles. The selection was based on content analysis following the essential landmarks of the researched problem: medication classification, types of con­sum­ption, influencing the ability to drive, categories of pa­tients with improvements in abilities in the presence of these treatments, social effects of public narratives, effects of incriminating norms, social responsibility of decision-ma­kers and professionals, practical assessment of cognitive, mo­tor and reaction abilities. The responsibility of politicians and health professionals is essential in developing evi­dence-based policies that promote road safety without com­pro­mi­sing access to necessary treatments. A balanced approach, which includes public education and counseling, is essential to protect patients’ rights and ensure fair regulation.